US › Healthcare

Precipio Inc (PRPO)

US · Healthcare · Diagnostics & Research

$18.62+0.16%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

$7.0M

Revenue YoY

+24.2%

Net profit

$-219,000

Profit YoY

-395.9%

EPS

$-0.12

Net margin

-3.1%

Key statistics

Market cap

$33.3M

Forward P/E

15.4

P/B

2.26

Book value

$8.25

EPS (TTM)

$-0.64

52-week high

$33.63

52-week low

$17.79

50-day MA

$23.62

200-day MA

$24.88

Beta

1.44

Analyst view

with an average price target of $19.00.

Shareholding

Insiders

12.67%

Institutions

17.78%

Largest institutional holders

Fund	Stake
Vanguard Capital Management, LLC	2.58%
BlackRock Inc	1.94%
Geode Capital Management, LLC	1.04%
Renaissance Technologies Corp	0.90%
Citadel Advisors Llc	0.82%
XTX Topco Ltd	0.53%
Vanguard Fiduciary Trust Co	0.53%
Dimensional Fund Advisors, Inc.	0.47%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Precipio Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.